| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |